Doxorubicin chemotherapy in breast cancer cells with high DUSP4 expression can lead to acquired chemoresistance by converting epithelial cells into mesenchymal (EMT) cells (epithelial-to-mesenchymal transition). Here, DUSP4 is linked to breast carcinoma.